-+ 0.00%
-+ 0.00%
-+ 0.00%

LANTERN PHARMA - APPOINTS DAVID MARGRAVE AS INTERIM CEO EFFECTIVE NOV 16, 2026 - SEC FILING

Reuters·11/18/2026 12:37:45

Please log in to view news